Skip to main content
CCLD logo

CCLD · CareCloud, Inc. · Financials

Track CCLD — free
$1.78 +0.01 (+0.28%)
Market Cap
$75.21M
Shares
42.49M
Volume · Oct 23 146.64K Avg daily vol (3M) 316.1K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$120.5M +8.7%
FY2025 Revenue FY2017–FY2025
Net Income
$10.8M +37.5%
FY2025 Net Income FY2013–FY2025
Operating Margin
9.41% +1.2pp
FY2025 Operating Margin FY2017–FY2025
Diluted EPS
$0.10 +135.7%
FY2025 Diluted EPS FY2013–FY2025
Operating Cash Flow
$28.56M +38.4%
FY2025 Operating Cash Flow FY2013–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
$128M – $132M $128.64M $120.5MG $110.84MG $117.06MG $138.83MG $139.6MG $105.12MG $64.44M $50.55M $31.81M — — — —
— $8.74M $6.38M $3.78M $4.74M $4.4M $4.41M $9.31M $871K $1.03M $1.08M $902.19K $659.18K $531.68K $386.11K
— $5.28M $4.82M $6.23M $9.65M $9.79M $8.79M $6.58M $1.52M $1.61M $1.11M $1.22M $467.45K $253.28K $248.98K
— $20.56M $18.39M $16.12M $21.46M $23.82M $24.27M $22.81M $17.91M $16.26M $11.74M $12.46M $11.97M $9.94M $4.74M
— — $12.45M $12.1M $12.4M $9.77M $10.23M $8.54M $2.06M $2.1M $3.65M $4.58M $4.18M $2.53M $715.1K
— $16.01M $14.96M $14.14M $14.4M $11.73M $12.2M $9.91M $3.01M $2.85M $4.3M $5.11M $4.6M $2.79M $948.53K
— — — $606K $645K — — — $49K — $275.63K — — — —
— $119.45M $109.16M $101.72M $164.17M $132.22M $136.07M $113.39M $64.37M $53.09M $36.33M $32.39M $27.54M $22.34M $10.6M
— $68.82M $64.46M $60.84M $70.82M $84.43M — — — — — — — — —
— $9.19M $11.34M $9.12M -$47.12M $6.61M $3.53M -$8.27M $67K -$2.54M -$4.52M -$7.9M -$4.46M -$4.04M -$127.52K
— — 9.41% 8.23% -40.25% 4.76% 2.53% -7.87% 0.1% -5.02% -14.22% — — — —
— $25.2M $26.3M $23.26M -$32.71M $18.34M $15.72M $1.63M $3.07M $314.01K -$222.22K -$2.79M $140.35K -$1.25M $821.02K
— -$90K -$265K -$298K -$883K -$637K -$96K $7000 -$625K $494.33K $332.08K -$53.28K $170.28K -$134.72K $230.15K
— $8.26M $11M $8.01M -$49.04M $5.61M $2.99M -$8.71M -$679K -$2.3M -$5.5M -$8.6M -$4.55M -$4.33M -$33.51K
— $270K $199K $160K -$364K $177K $157K $103K $193K -$157.39K $67.81K $196.8K $137.79K $176.53K $144.49K
— $7.99M $10.8M $7.85M -$48.67M $5.43M $2.84M -$8.81M -$872K -$2.14M -$5.57M -$8.8M -$4.69M -$4.51M -$178K
— — 8.96% 7.08% -41.58% 3.91% 2.03% -8.38% -1.35% -4.23% -17.49% — — — —
— $2.96M $3.89M -$4.46M -$64.35M -$10.09M -$11.22M -$22.69M -$7.26M -$6.96M -$7.6M -$9.55M -$4.89M -$4.51M -$178K
— $8.23M $10.82M $7.72M -$49.51M $4.15M $2.09M -$8.97M -$294K -$2.84M -$5.91M -$8.77M -$4.88M -$4.53M -$287.58K
USD/shares — $0.09 $0.10 -$0.28 -$4.11 -$0.67 -$0.77 — — — — — — -$0.64 -$0.03
USD/shares $0.20 – $0.23 $0.09 $0.10G -$0.28 -$4.11 -$0.67 — — — — — — — -$0.64 -$0.03
shares — — 37.79M 16.15M 15.67M 15.11M 14.54M 12.68M 12.09M 11.72M 11.01M 10.04M 9.73M 7.08M 5.1M
shares — — 37.95M 16.15M 15.67M 15.11M 14.54M 12.68M 12.09M 11.72M 11.01M 10.04M 9.73M 7.08M 5.1M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2016: $668.18K in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent line of credit borrowings 2026-06-30 USD 9,000,000 10-Q filed 2026-08-06
Operating lease liabilities 2026-06-30 USD 5,035,000 10-Q filed 2026-08-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 1,573,000
Noncurrent operating lease liabilities
USD 3,462,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 2.82×
EV/EBIT
—
Peer median 28.19×
P/E (TTM)
—
Peer median 37.83×

Peer medians compare against the 23 similar-size Health Information Services companies (of 53 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Healthcare IT $106,566,000 $96,405,000 $103,683,000 $125,276,000 $127,080,000 —
Medical Practice Management $13,933,000 $14,432,000 $13,376,000 $13,550,000 $12,519,000 —
Healthcare IT — — — — — $93,324,000
Medical Practice Management — — — — — $11,798,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022
Chronic Care Management $2,800,000 $3,000,000 $1,500,000 $208,000
Remote Patient Monitoring $794,000 $779,000 $400,000 $6,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Healthcare IT $17,600,000 $12,976,000 -$39,129,000 $15,439,000 $11,682,000 —
Medical Practice Management -$313,000 $1,264,000 $632,000 $631,000 $130,000 —
UnallocatedCorporateExpenses — — -$8,618,000 -$9,460,000 -$8,283,000 —
Healthcare IT — — — — — -$2,317,000
Medical Practice Management — — — — — $301,000
Unallocated Corporate Expenses — — — — — -$6,255,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Healthcare IT 16.5% 13.5% -37.7% 12.3% 9.2% —
Medical Practice Management -2.2% 8.8% 4.7% 4.7% 1% —
Healthcare IT — — — — — -2.5%
Medical Practice Management — — — — — 2.6%
Key facts CIK 1582982 CUSIP 14167R100 13F (30d) 4 filings 4 filers Visit website Investor relations